Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-17

Clinical Trial Update: Alfacalcidol Supplementation on Levator Ani Muscle Strength of Menopausal Pelvic Organ Prolapse Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating alfacalcidol supplementation on levator ani muscle strength in menopausal patients with pelvic organ prolapse has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfacalcidol (alfacalcidol)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Pelvic Organ Prolapse | Phase 3 | Status: COMPLETED